sparfloxacin has been researched along with Infections, Staphylococcal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (68.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Bachand, B; Barnes, MH; Bethell, R; Brown, NC; Butler, MM; Cadilhac, C; Charron, S; Comstock, J; Dix, EJ; Foster, KA; Holm, KA; LaMarr, WA; Lamothe, S; Long, ZY; Manikowski, A; Motorina, I; Storer, R; Tarantino, PM; Wright, GE; Xu, WC; Zhi, C | 1 |
| Anderson, BE; Burda, WN; Cormier, R; Edlinger, J; Harrington, L; Kapolka, R; Kodigepalli, KM; Roma, G; Shaw, LN; Thomas, J; Turos, E | 1 |
| Ambhore, NP; Dandagi, PM; Gadad, AP | 1 |
| Cagni, A; Chuard, C; Lew, DP; Schrenzel, J; Vaudaux, PE | 1 |
| Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ | 1 |
| Braveny, I; Milatovic, D; Voss, A; Wallrauch, C | 1 |
| Desnottes, JF; Diallo, N | 1 |
| Bauchet, J; Cochereau-Massin, I; Faurisson, F; Marrakchi-Benjaafar, S; Pocidalo, JJ; Saleh-Mghir, A; Vallee, E; Vallois, JM | 1 |
| Belmatoug, N; Bleton, R; Carbon, C; Crémieux, AC; Garry, L; Manteau, M; Massias, L; Mazière, B; Mghir, AS; Sales, N | 1 |
| Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
| Biavasco, F; Mingoia, M; Montanari, MP; Prenna, M; Ripa, S; Varaldo, PE | 1 |
| Engler, B; Fluit, AC; Hadding, U; Heinz, HP; Hofmann, B; Jones, ME; Lückefahr, M; Schmitz, FJ; Verhoef, J | 1 |
| Cascina, A; Fietta, A; Morosini, M | 1 |
| Feistauer, SM; Georgopoulos, A; Georgopoulos, M; Graninger, W; Pfleger, S | 1 |
| Inoue, M; Kojima, T; Mitsuhashi, S; Yoshida, S | 1 |
1 trial(s) available for sparfloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
15 other study(ies) available for sparfloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; DNA Polymerase III; Drug Resistance, Bacterial; Gram-Positive Bacteria; Male; Mice; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors; Toxicity Tests, Acute; Uracil | 2006 |
Studies on the antimicrobial properties of N-acylated ciprofloxacins.
Topics: Acylation; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bartonella; Bartonella Infections; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2012 |
Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Chick Embryo; Chitosan; Chlorocebus aethiops; Conjunctivitis, Bacterial; Delayed-Action Preparations; Drug Stability; Female; Fluoroquinolones; Hypromellose Derivatives; Male; Nanoparticles; Particle Size; Poloxamer; Rabbits; Solubility; Staphylococcal Infections; Surface-Active Agents; Suspensions; Vero Cells; Water | 2016 |
Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Foreign Bodies; Guinea Pigs; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
[In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
Effect of sparfloxacin on Staphylococcus aureus adhesiveness and phagocytosis.
Topics: Animals; Anti-Infective Agents; Bacterial Adhesion; Fluoroquinolones; Guinea Pigs; Humans; In Vitro Techniques; Macrophages, Peritoneal; Microscopy, Electron, Scanning; Mouth Mucosa; Phagocytosis; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 1994 |
Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.
Topics: Animals; Anti-Infective Agents; Endophthalmitis; Eye; Fluoroquinolones; Half-Life; Injections; Injections, Intramuscular; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Vitreous Body | 1993 |
Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.
Topics: Animals; Anti-Infective Agents; Autoradiography; Bone and Bones; Diffusion; Fluoroquinolones; Joint Prosthesis; Microbial Sensitivity Tests; Pefloxacin; Prosthesis-Related Infections; Quinolones; Rabbits; Staphylococcal Infections | 1996 |
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1998 |
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Polymerase Chain Reaction; Quinolines; Reserpine; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cell Culture Techniques; Fluoroquinolones; Humans; Kinetics; Monocytes; Mycobacterium tuberculosis; Rifabutin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Tuberculosis | 2001 |
Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Topics: Abscess; Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Fluoroquinolones; Half-Life; Kidney Diseases; Methicillin Resistance; Mice; Quinolones; Staphylococcal Infections | 1992 |
Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Staphylococcal Infections; Staphylococcus aureus | 1991 |